Chemed CHE Segment Vitas — Patient Care Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept che:PatientCareExpense.
The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's segment vitas — patient care expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Chemed's segment vitas — patient care expense?
- Chemed (CHE) reported segment vitas — patient care expense of $45.85M in Q1 2026.
- How has Chemed's segment vitas — patient care expense changed year-over-year?
- Chemed's segment vitas — patient care expense increased by 13.5% year-over-year, from $40.38M to $45.85M.
- What is the long-term trend for Chemed's segment vitas — patient care expense?
- Over 3 years (2022 to 2025), Chemed's segment vitas — patient care expense has grown at a 12.7% compound annual growth rate (CAGR), from $116.34M to $166.68M.
- What does segment vitas — patient care expense mean?
- Represents the direct costs incurred by the hospice and palliative care segment to provide medical and support services to patients. This includes expenses related to clinical staff, medical supplies, and direct patient care delivery. Monitoring this metric helps assess the operational cost efficiency of delivering specialized healthcare services.